Overview
Sebastian Weigang practices practicing medicine in Freiburg, Germany.
His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS) and Oral Herpes.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sebastian Weigang
Is Sebastian Weigang a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?
MediFind is an objective health platform that identifies experts based on real-world data. Sebastian Weigang is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sebastian Weigang participate in research or clinical trials?
Yes. Sebastian Weigang has published 15 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Sebastian Weigang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Oral HerpesMr. Weigang isExperienced. Learn about Oral Herpes.
- Severe Acute Respiratory Syndrome (SARS)Mr. Weigang isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).